REVIEW
|
doi:10.20944/preprints202309.1180.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
myeloma; daratumumab; bispecific antibodies; chimeric antigen receptor T-cells; immunotherapy
Online: 19 September 2023 (05:28:58 CEST)
REVIEW
|
doi:10.20944/preprints202007.0016.v1
Subject:
Medicine And Pharmacology,
Pharmacology And Toxicology
Keywords:
myeloma; BCMA; bispecific T-cell engager; antibody-drug conjugates; chimeric antigen receptor T-cells; belantamab mafodotin; idecabtagene vicleucel; JNJ-68284528
Online: 3 July 2020 (07:30:57 CEST)